Atlas Trials

REGEnLIFE RGn530 - Feasibility Pilot

Clinical trial NCT03672474 · TERMINATED

Trial details

NCT number
NCT03672474
Sponsor
University Hospital, Montpellier
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2018-09-07
Primary completion
2020-05-13
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.